4.7 Review

Exosome therapeutics for lung regenerative medicine

期刊

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/20013078.2020.1785161

关键词

Exosome; regenerative medicine; lung spheroid cell; stem cell

资金

  1. U.S. National Institute of Health [HL123920, HL137093, HL144002, HL146153, HL147357]
  2. American Heart Association [18TPA34230092, 19EIA34660286]
  3. North Carolina Biotechnology Center [2019TRG6712]

向作者/读者索取更多资源

Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types. Initially viewed as cellular garbage with no biological functions, exosomes are now recognized for their therapeutic potential and used in regenerative medicine. Cell-derived exosomes are released into almost all biological fluids, making them abundant and accessible vesicles for a variety of diseases. These naturally occurring nanoparticles have a wide range of applications including drug delivery and regenerative medicine. Exosomes sourced from a specific tissue have been proven to provide greater therapeutic effects to their native tissue, expanding exosome sources beyond traditional cell lines such as mesenchymal stem cells. However, standardizing production and passing regulations remain obstacles, due to variations in methods and quantification techniques across studies. Additionally, obtaining pure exosomes at sufficient quantities remains difficult due to the heterogeneity of exosomes. In this review, we will underline the uses of exosomes as a therapy and their roles in lung regenerative medicine, as well as current challenges in exosome therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据